We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
RANDOX LABORATORIES

Download Mobile App




Nanoparticle-Based Hydrogel Liquefies Under Pressure for Delivery by Syringe

By LabMedica International staff writers
Posted on 04 Mar 2015
Print article
Image: Scanning electron microscopy images, taken at different magnifications, show the structure of new hydrogels made of nanoparticles interacting with long polymer chains. (Photo courtesy of Massachusetts Institute of Technology).
Image: Scanning electron microscopy images, taken at different magnifications, show the structure of new hydrogels made of nanoparticles interacting with long polymer chains. (Photo courtesy of Massachusetts Institute of Technology).
A hydrogel that liquefies under pressure but reforms as a gel when the pressure is released has been recruited as a delivery system for both hydrophobic and hydrophilic anticancer agents.

Investigators at the Massachusetts Institute of Technology (Cambridge, USA) created the hydrogel by mixing PEG-PLA (polyethylene glycol- polymerized lactic acid) nanoparticles with polymeric cellulose. Each polymer chain formed weak bonds with a number of nanoparticles, producing a loosely woven lattice of polymers and nanoparticles. As each attachment point was fairly weak, the bonds disassociated under the mechanical stress of being injected through a syringe. Once the shear forces had abated, the polymers and nanoparticles formed new attachments with different partners, returning the conglomerate to the gel form.

The composition of the gel allowed it to be loaded simultaneously with two different types of drugs. The PEG-PLA nanoparticles had an inner core capable of carrying small-molecule hydrophobic drugs, which include many chemotherapy agents. At the same time, the cellulose polymer, which existed in aqueous solution, could transport hydrophilic molecules such as proteins, including antibodies and growth factors.

A detailed description of the hydrogel as well as results of an in vivo experiment in which gels injected under the skin of mice survived and successfully released two drugs—one hydrophobic and one hydrophilic—over a period of several days, was published in the February 19, 2015, online edition of the journal Nature Communications.

“We are working with really simple materials,” said contributing author Dr. Mark Tibbitt, a postdoctoral researcher at the Massachusetts Institute of Technology. “They do not require any advanced chemical functionalization. Now you have a gel that can change shape when you apply stress to it, and then, importantly, it can re-heal when you relax those forces. That allows you to squeeze it through a syringe or a needle and get it into the body without surgery.”

Related Links:

Massachusetts Institute of Technology


Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
Complement 3 (C3) Test
GPP-100 C3 Kit
New
Gold Member
Magnetic Bead Separation Modules
MAG and HEATMAG

Print article

Channels

Clinical Chemistry

view channel
Image: The 3D printed miniature ionizer is a key component of a mass spectrometer (Photo courtesy of MIT)

3D Printed Point-Of-Care Mass Spectrometer Outperforms State-Of-The-Art Models

Mass spectrometry is a precise technique for identifying the chemical components of a sample and has significant potential for monitoring chronic illness health states, such as measuring hormone levels... Read more

Molecular Diagnostics

view channel
Image: AI analysis of DNA fragmentomes and protein biomarkers noninvasively detects ovarian cancer (Photo courtesy of Adobe Stock)

Blood-Based Machine Learning Assay Noninvasively Detects Ovarian Cancer

Ovarian cancer is one of the most common causes of cancer deaths among women and has a five-year survival rate of around 50%. The disease is particularly lethal because it often doesn't cause symptoms... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Immunology

view channel
Image: The groundbreaking treatment approach has shown promise in hard-to-treat cancers (Photo courtesy of 123RF)

Genetic Testing Combined With Personalized Drug Screening On Tumor Samples to Revolutionize Cancer Treatment

Cancer treatment typically adheres to a standard of care—established, statistically validated regimens that are effective for the majority of patients. However, the disease’s inherent variability means... Read more

Pathology

view channel
Image: The device can serve as a sample pretreatment tool for cytological diagnosis of malignant effusions (Photo courtesy of Microsystems & Nanoengineering: Zhu, Z., Ren, H., Wu, D. et al.)

Microfluidic Device for Cancer Detection Precisely Separates Tumor Entities

Tumor cell clusters are increasingly recognized as crucial in cancer pathophysiology, with growing evidence of their increased resistance to treatment and higher metastatic potential compared to single tumor cells.... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.